Detalles de la búsqueda
1.
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
Br J Haematol
; 204(3): 839-848, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009548
2.
Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era.
Ann Hematol
; 102(7): 1897-1905, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246974
3.
Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities.
Ann Hematol
; 97(2): 267-276, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29130134
4.
25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it?
Support Care Cancer
; 26(8): 2825-2832, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29511954
5.
Clinicopathological and fluorescence in situ hibridisation analysis of primary testicular diffuse large B-cell lymphoma: a single-centre case series.
Pol J Pathol
; 69(2): 136-142, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30351860
6.
Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients.
Am J Hematol
; 91(10): 1014-9, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27380861
7.
The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience.
Br J Neurosurg
; 30(1): 80-5, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26337736
8.
Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.
Int J Mol Sci
; 17(5)2016 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27164089
9.
BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
J BUON
; 20(3): 820-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26214636
10.
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review.
Crit Rev Oncol Hematol
; 196: 104293, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346460
11.
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models.
Blood Cancer J
; 13(1): 157, 2023 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833260
12.
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review.
Clin Lymphoma Myeloma Leuk
; 22(11): e981-e991, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948478
13.
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study.
Leuk Lymphoma
; 63(9): 2074-2083, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35437098
14.
Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.
Ann Med
; 54(1): 713-722, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35238275
15.
The clinical applicability of current prognostic models in follicular lymphoma: A systematic review.
Crit Rev Oncol Hematol
; 164: 103418, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246773
16.
Prognostic models in primary central nervous system lymphoma patients: A systematic review.
Crit Rev Oncol Hematol
; 161: 103341, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865995
17.
Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic Review.
Clin Epidemiol
; 12: 537-555, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32581596
18.
Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review.
Crit Rev Oncol Hematol
; 133: 1-16, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30661646
19.
Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment.
Blood Rev
; 32(2): 144-158, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29126566
20.
The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
Oncol Res Treat
; 40(10): 616-620, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28950269